I fight for James retweetledi

Breaking News: @CatabasisPharma and @DuchenneUK have partnered to evaluate the safety and efficacy of the drug #edasalonexent in non-ambulatory people with #DMD. The clinical trial will be recruiting in the UK. Read more >> bit.ly/2BmYBwX

English


















